Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients

Journal of Immunology

Volumn 198, Issue 1, 2017, Pages 94-101

  Redondo Pachón, Dolores ^a,b   Crespo, Marta ^a,b   Yélamos, Jose ^a,b   Muntasell, Aura ^b   Pérez Sáez, María José ^a   Pérez Fernández, Silvia ^b   Vila, Joan ^a   Vilches, Carlos ^c   Pascual, Julio ^a,b   López Botet, Miguel ^a,b,d  

^a HOSPITAL DEL MAR   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CELL EXPANSION; CELLULAR DISTRIBUTION; COHORT ANALYSIS; CONTROLLED STUDY; COPY NUMBER VARIATION; CROSS-SECTIONAL STUDY; CYTOMEGALOVIRUS INFECTION; FEMALE; FOLLOW UP; GENE; GENE FREQUENCY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNOPHENOTYPING; INFECTION CONTROL; INFECTION RISK; KIDNEY GRAFT; LYMPHOCYTE SUBPOPULATION; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER CELL; NKG2C GENE; PRIORITY JOURNAL; PROSPECTIVE STUDY; VIREMIA; ADVERSE EFFECTS; CYTOMEGALOVIRUS INFECTIONS; FLOW CYTOMETRY; GENETICS; GENOTYPE; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; INCIDENCE; KIDNEY TRANSPLANTATION; MIDDLE AGED;

KLRC2 PROTEIN, HUMAN; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY C;

ADAPTIVE IMMUNITY; ADULT; COHORT STUDIES; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; GENOTYPE; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOPHENOTYPING; INCIDENCE; KIDNEY TRANSPLANTATION; KILLER CELLS, NATURAL; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; VIREMIA;

EID: 85006984172     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1601236     Document Type: Article

References (44)

1. Mocarski, E. S., T. Shenk, P. D. Griffiths, and R. F. Pass. 2013. Cytomegaloviruses. In Fields Virology, 6th Ed. D. M. Knipe, and P. M. Howley, eds. Lippincott Williams & Wilkins, Philadelphia, p. 1960-2015.
2. Cannon, M. J., D. S. Schmid, and T. B. Hyde. 2010. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 20: 202-213.
3. Sagedal, S., A. Hartmann, K. P. Nordal, K. Osnes, T. Leivestad, A. Foss, M. Degré, P. Fauchald, and H. Rollag. 2004. Impact of early cytomegalovirus infection and disease on long-term recipient and kidney graft survival. Kidney Int. 66: 329-337.
4. Razonable, R. R., and R. T. Hayden. 2013. Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation. Clin. Microbiol. Rev. 26: 703-727.
5. Tong, C. Y., A. Bakran, J. S. Peiris, P. Muir, and C. S. Herrington. 2002. The association of viral infection and chronic allograft nephropathy with graft dysfunction after renal transplantation. Transplantation 74: 576-578.
6. Bestard, O., M. Lucia, E. Crespo, B. Van Liempt, D. Palacio, E. Melilli, J. Torras, I. Llaudó, G. Cerezo, O. Taco, et al. 2013. Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation. Am. J. Transplant. 13: 1793-1805.
7. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
8. López-Botet, M., A. Muntasell, and C. Vilches. 2014. The CD94/NKG2C+ NK-cell subset on the edge of innate and adaptive immunity to human cytomegalovirus infection. Semin. Immunol. 26: 145-151.
9. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
10. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K. J. Malmberg, J. Klingström, C. Ahlm, and H. G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
11. Béziat, V., O. Dalgard, T. Asselah, P. Halfon, P. Bedossa, A. Boudifa, B. Hervier, I. Theodorou, M. Martinot, P. Debré, et al. 2012. CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
12. Gumá, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. López-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.
13. Lopez-Vergès, S., J. M. Milush, B. S. Schwartz, M. J. Pando, J. Jarjoura, V. A. York, J. P. Houchins, S. Miller, S. M. Kang, P. J. Norris, et al. 2011. Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
14. Della Chiesa, M., M. Falco, M. Podestà, F. Locatelli, L. Moretta, F. Frassoni, and A. Moretta. 2012. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 119: 399-410.
15. Foley, B., S. Cooley, M. R. Verneris, M. Pitt, J. Curtsinger, X. Luo, S. Lopez-Vergès, L. L. Lanier, D. Weisdorf, and J. S. Miller. 2012. Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function. Blood 119: 2665-2674.
16. O'Sullivan, T. E., J. C. Sun, and L. L. Lanier. 2015. Natural killer cell memory. Immunity 43: 634-645.
17. Schlums, H., F. Cichocki, B. Tesi, J. Theorell, V. Béziat, T. D. Holmes, H. Han, S. C. Chiang, B. Foley, K. Mattsson, et al. 2015. Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function. Immunity 42: 443-456.
18. Lee, J., T. Zhang, I. Hwang, A. Kim, L. Nitschke, M. Kim, J. M. Scott, Y. Kamimura, L. L. Lanier, and S. Kim. 2015. Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals. Immunity 42: 431-442.
19. Muntasell, A., A. Pupuleku, E. Cisneros, A. Vera, M. Moraru, C. Vilches, and M. López-Botet. 2016. Relationship of NKG2C copy number with the distribution of distinct cytomegalovirus-induced adaptive NK cell subsets. J. Immunol. 196: 3818-3827.
20. Costa-García, M., A. Vera, M. Moraru, C. Vilches, M. López-Botet, and A. Muntasell. 2015. Antibody-mediated response of NKG2Cbright NK cells against human cytomegalovirus. J. Immunol. 194: 2715-2724.
21. Zhang, T., J. M. Scott, I. Hwang, and S. Kim. 2013. Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRγ deficiency. J. Immunol. 190: 1402-1406.
22. Wu, Z., C. Sinzger, G. Frascaroli, J. Reichel, C. Bayer, L. Wang, R. Schirmbeck, and T. Mertens. 2013. Human cytomegalovirus-induced NKG2C(hi) CD57(hi) natural killer cells are effectors dependent on humoral antiviral immunity. J. Virol. 87: 7717-7725.
23. Gumá, M., M. Budt, A. Sáez, T. Brckalo, H. Hengel, A. Angulo, and M. López-Botet. 2006. Expansion of CD94/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107: 3624-3631.
24. Rölle, A., J. Pollmann, E. M. Ewen, V. T. Le, A. Halenius, H. Hengel, and A. Cerwenka. 2014. IL-12-producing monocytes and HLA-E control HCMV-driven NKG2C+ NK cell expansion. J. Clin. Invest. 124: 5305-5316.
25. Miyashita, R., N. Tsuchiya, K. Hikami, K. Kuroki, T. Fukazawa, M. Bijl, C. G. Kallenberg, H. Hashimoto, T. Yabe, and K. Tokunaga. 2004. Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 16: 163-168.
26. Moraru, M., M. Cañizares, A. Muntasell, R. de Pablo, M. López-Botet, and C. Vilches. 2012. Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 80: 184-187.
27. Muntasell, A., M. López-Montañés, A. Vera, G. Heredia, N. Romo, J. Peñafiel, M. Moraru, J. Vila, C. Vilches, and M. López-Botet. 2013. NKG2C zygosity influences CD94/NKG2C receptor function and the NK-cell compartment redistribution in response to human cytomegalovirus. Eur. J. Immunol. 43: 3268-3278.
28. Goodier, M. R., M. J. White, A. Darboe, C. M. Nielsen, A. Goncalves, C. Bottomley, S. E. Moore, and E. M. Riley. 2014. Rapid NK cell differentiation in a population with near-universal human cytomegalovirus infection is attenuated by NKG2C deletions. Blood 124: 2213-2222.
29. Crespo, M., J. Yélamos, D. Redondo, A. Muntasell, M. J. Perez-Saéz, M. López-Montañés, C. García, A. Torio, M. Mir, J. J. Hernández, et al. 2015. Circulating NK-cell subsets in renal allograft recipients with anti-HLA donor-specific antibodies. Am. J. Transplant. 15: 806-814.
30. Humar, A., M. Michaels, AST ID Working Group on Infectious Disease Monitoring. 2006. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am. J. Transplant. 6: 262-274.
31. Efron, B., and G. Gong. 1983. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am. Stat. 37: 36-49.
32. López-Botet, M., A. Muntasell, J. E. Martínez-Rodríguez, M. López-Montañés, M. Costa-García, and A. Pupuleku. 2016. Development of the adaptive NK cell response to human cytomegalovirus in the context of aging. Mech. Ageing Dev. 158: 23-26.
33. Hoffmann, U., C. Neudörfl, K. Daemen, J. Keil, M. Stevanovic-Meyer, F. Lehner, H. Haller, C. Blume, and C. S. Falk. 2015. NK cells of kidney transplant recipients display an activated phenotype that is influenced by immunosuppression and pathological staging. PLoS One 10: e0132484.
34. Vieira Braga, F. A., K. M. Hertoghs, R. A. van Lier, and K. P. van Gisbergen. 2015. Molecular characterization of HCMV-specific immune responses: parallels between CD8(+) T cells, CD4(+) T cells, and NK cells. Eur. J. Immunol. 45: 2433-2445.
35. Lúcia, M., E. Crespo, J. M. Cruzado, J. M. Grinyó, and O. Bestard. 2014. Human CMV-specific T-cell responses in kidney transplantation; toward changing current risk-stratification paradigm. Transpl. Int. 27: 643-656.
36. Kaminski, H., I. Garrigue, L. Couzi, B. Taton, T. Bachelet, J. F. Moreau, J. Déchanet-Merville, R. Thiébaut, and P. Merville. 2016. Surveillance of γδ T cells predicts cytomegalovirus infection resolution in kidney transplants. J. Am. Soc. Nephrol. 27: 637-645.
37. Bigley, A. B., G. Spielmann, N. Agha, D. P. O'Connor, and R. J. Simpson. 2016. Dichotomous effects of latent CMV infection on the phenotype and functional properties of CD8+ T-cells and NK-cells. Cell. Immunol. 300: 26-32.
38. Bengnér, M., V. Béziat, J. Ernerudh, B. O. Nilsson, S. Löfgren, A. Wikby, K. J. Malmberg, and J. Strindhall. 2014. Independent skewing of the T cell and NK cell compartments associated with cytomegalovirus infection suggests division of labor between innate and adaptive immunity. Age (Dordr.) 36: 571-582.
39. -/- umbilical cord blood. J. Immunol. 192: 1471-1479.
40. Hadaya, K., C. de Rham, C. Bandelier, C. Bandelier, S. Ferrari-Lacraz, S. Jendly, T. Berney, L. Buhler, L. Kaiser, J. D. Seebach, et al. 2008. Natural killer cell receptor repertoire and their ligands, and the risk of CMV infection after kidney transplantation. Am. J. Transplant. 8: 2674-2683.
41. Stern, M., K. Hadaya, G. Hönger, P. Y. Martin, J. Steiger, C. Hess, and J. Villard. 2011. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation. Am. J. Transplant. 11: 1302-1307.
42. Liu, L. L., J. Landskron, E. H. Ask, M. Enqvist, E. Sohlberg, J. A. Traherne, Q. Hammer, J. P. Goodridge, S. Larsson, J. Jayaraman, et al. 2016. Critical role of CD2 co-stimulation in adaptive Natural Killer cell responses revealed in NKG2C-deficient humans. Cell Reports 15: 1088-1099.
43. Owers, D. S., A. C. Webster, G. F. Strippoli, K. Kable, and E. M. Hodson. 2013. Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients. Cochrane Database Syst. Rev. 2: CD005133 10.1002/14651858.
44. Blumberg, E. A., I. A. Hauser, S. Stanisic, E. Mueller, K. Berenson, C. G. Gahlemann, A. Humar, and A. G. Jardine. 2010. Prolonged prophylaxis with valganciclovir is cost effective in reducing posttransplant cytomegalovirus disease within the United States. Transplantation 90: 1420-1426.